3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow Intercept Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Single Dose and Multiple Dose Trial to Assess Pharmacokinetics of Obeticholic Acid (OCA) OCA 5 mg, OCA 10 mg, OCA 25 mg - Healthy | Phase 1 | Completed | Intercept Pharmaceuticals | 24 | 2013-10-01 | 2013-12-05 |
| Effect of Food on Pharmacokinetics of Obeticholic Acid (OCA) OCA 10 mg, OCA 25 mg - Healthy | Phase 1 | Completed | Intercept Pharmaceuticals | 32 | 2013-08-01 | 2014-08-08 |
| Hepatic Impairment Trial of Obeticholic Acid obeticholic acid 10 mg - Hepatic Impairment | Phase 1 | Completed | Intercept Pharmaceuticals | 32 | 2013-06-01 | 2013-10-24 |
obeticholic acid (3)
United States (3)
David Shapiro, MD (2) · David Shaprio, M.D. (1) · Terry E. O'Reilly, MD (1)